发明名称 METHODS FOR DIAGNOSING AND MONITORING TREATMENT OF LEWY BODY DEMENTIA BY ASSESSING DOPAMINE TRANSPORTER LEVEL
摘要 A method of diagnosing Lewy Body Dementia in a human patient by assessing the level of dopamine transporter in at least one region of the patient's central nervous system, where a lowered level of dopamine transporter in the patient is indicative of Lewy Body Dementia. In embodiments of the invention, assessment of dopamine transporter levels includes assessing binding of a dopamine transporter ligand to the dopamine transporters using PET or SPECT.
申请公布号 US2016121003(A1) 申请公布日期 2016.05.05
申请号 US201614992510 申请日期 2016.01.11
申请人 Alseres Pharmaceuticals, Inc. 发明人 Hurtt Mark
分类号 A61K51/04;A61K31/133;A61K31/445;A61K31/473;A61K31/27 主分类号 A61K51/04
代理机构 代理人
主权项 1. A method of treating Lewy Body Dementia in a human patient by the steps of: (a) administering to a patient a labeled dopamine transporter ligand; and (b) assessing the amount of said labeled dopamine transporter ligand that is bound to dopamine transporter in at least one region of said patient's central nervous system, wherein a lowered level of said dopamine transporter in said patient is diagnostic of Lewy Body Dementia, and the step of treating patients diagnosed with Lewy Body Dimentia by administration of a therapeutic amount of tacrine or rivastagmine.
地址 Hopkinton MA US